dilevalol has been researched along with baci-im in 1 studies
| Studies (dilevalol) | Trials (dilevalol) | Recent Studies (post-2010) (dilevalol) | Studies (baci-im) | Trials (baci-im) | Recent Studies (post-2010) (baci-im) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 22 | 0 | 10 |
| Protein | Taxonomy | dilevalol (IC50) | baci-im (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 5.377 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 1.923 | |
| Undecaprenyl-diphosphatase | Escherichia coli K-12 | 5.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
1 other study(ies) available for dilevalol and baci-im
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |